Business
Great-West Lifeco announces Normal Course Issuer Bid
Great-West Lifeco announces Normal Course Issuer Bid Canada NewsWire TSX: GWO ...
About this update from Great-west Lifeco Inc.
[{"type":"text","content":"\n\n\nGreat-West Lifeco announces Normal Course Issuer Bid\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntar{\nTEXT-ALIGN: RIGHT\n}\n\n\n\n\n\nCanada NewsWire\n\n\nTSX: GWO\nWINNIPEG, MB, Jan. 02, 2026 /CNW/ - Great-West Lifeco Inc. (\"Lifeco\") announced today that it has received approval from the Toronto Stock Exchange (\"TSX\") to renew its Normal Course Issuer Bid (\"NCIB\"). \n\n\n\n\n\n\n\nUnder the renewed NCIB, Lifeco may purchase for cancellation up to 20,000,000 common shares (\"Shares\"), representing approximately 2.2% of its 907,158,831 issued and outstanding Shares on December 23, 2025. The NCIB will commence on January 6, 2026 and continue until the earlier of January 5, 2027 and the date Lifeco completes its purchases pursuant to the notice of intention filed with the TSX. Based on the average daily trading volume on the TSX of 1,989,988 for the six months preceding November 30, 2025 (net of repurchases by Lifeco during that period), daily purchases will be limited to 497,497 Shares, other than block purchase exceptions. Purchases under the NCIB will be made at prevailing market prices through the facilities of the TSX, other designated exchanges and/or other alternative Canadian trading systems or by other means permitted by applicable law. Any Shares purchased by Lifeco pursuant to the NCIB will be cancelled. The actual number of Shares which may be purchased and the timing of any purchases will be determined by Lifeco management, subject to TSX rules and applicable law.\nLifeco's Board of Directors (the \"Board\") has authorized the renewed NCIB because, in the Board's opinion, such purchases constitute an appropriate use of funds which will benefit both Lifeco and its shareholders. Lifeco will use the renewed NCIB to mitigate the dilutive effect of issuing securities under Lifeco's Stock Option Plan and for other capital management purposes.\nUnder its prior NCIB (as amended on September 5, 2025), Lifeco received approval from the TSX to purchase up to 40,000,000 Shares from January 6, 2025 to January 5, 2026. As of December 23, 2025, L...